查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1857903

草铵膦市场按应用、作物、製剂和最终用途划分－2025-2032年全球预测

Glufosinate Market by Application, Crop, Formulation, End Use - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，草铵膦市场规模将达到 42.9 亿美元，复合年增长率为 10.20%。

关键市场统计数据
基准年 2024 19.7亿美元
预计年份：2025年 21.7亿美元
预测年份 2032 42.9亿美元
复合年增长率 (%) 10.20%

全面介绍草铵膦领域的最新进展，概述其农艺作用和监管压力、供应链动态和商业性相关性。

草铵膦在现代农艺中占据着举足轻重的地位，它既是综合杂草控制方案中非Glyphosate的替代品，也是抗性管理策略的补充。草铵膦的作用机制、药理特性和製剂灵活性使其在各种种植系统中保持相关性，而不断变化的监管审查和种植者偏好也在持续改变该产品的使用方式。在过去的几个种植季中，相关人员推动了製剂、施用时间和管理方法的创新，力求在药效与环境和监管因素之间取得平衡。

除了农艺性能外，产品的商业性生命週期还受到上游原料采购、组合药物供应和下游监管批准的影响。需求模式反映了合规性驱动因素和实际田间表现，因为种植者核准更具韧性的杂草控制方案，尤其关注杂草压力大且有抗药性风险的作物。因此，製造商、配方商和经销商都在强调将化学、耕作和机械手段结合的综合方法。

展望未来，引言部分概述了影响产品开发、市场进入和农场应用等决策的交叉因素。透过监管动态、营运限制和终端用户期望来建立竞争格局，本部分为深入分析市场区隔、区域动态以及相关人员为保持竞争力并适应市场变化而需要采取的策略性应对措施奠定了基础。

农艺、技术和商业性法规的变革力量正在塑造草铵膦策略和供应链定位的创新。

由于监管环境的调整、抗药性管理的需求以及对永续性的日益重视，草铵膦的应用格局正在转变。多个司法管辖区更严格的环境和毒理学审查流程迫使企业重新评估其註册策略，并投资于更完善的安全性和管理专案。同时，抗除草剂杂草的蔓延提升了替代作用机制的价值，使草铵膦成为轮作计画和综合杂草管理通讯协定中的关键组成部分。

技术和商业性变革也显而易见。配方科学的进步，提高了耐雨性、作物选择性和桶混相容性，拓宽了施药人员的工作窗口。数位化农艺工具实现了精准施药，在最大限度提高药效的同时减少了活性成分的使用；而主导的决策支援则帮助顾问制定能够延缓抗药性产生的组合方案。在供应方面，配方商和经销商之间日益紧密的整合正在重塑产品的获取和定价动态，而伙伴关係和契约製造在其中扮演着越来越重要的角色。

此外，主要买家和零售商的永续性承诺正促使供应链减少环境足迹并展现良好的管理能力。法律规范、农业要求和商业性永续性需求的共同作用，正在推动产品组合的合理化和创新，这不仅给现有参与企业也带来了挑战，同时也带来了机会。

评估2025年关税对草铵膦采购、生产和打入市场策略的供应链中断和商业成本影响

美国2025年实施的关税和贸易措施，导致草铵膦价值链中各参与者的成本结构和采购决策发生重大变化。某些前驱物化学品和製剂原料关税的提高，增加了部分依赖进口的生产商的到岸成本，促使他们迅速重新评估供应商关係和物流模式。这些贸易政策的变化凸显了供应链透明度、多元化采购策略和本地生产方案对于保护利润率和维持供应连续性的重要性。

因此，製造商和配方师不得不权衡将更高的成本转嫁给下游客户与承受利润率压缩之间的利弊。在许多情况下，商务团队实施了有针对性的价格调整，并加强了价值讯息，以证明价格调整的合理性；与此同时，采购部门加快了对低关税地区替代供应商的资格审核。关税环境也强化了远期合约和库存避险的奖励，企业需要在营运成本方面做出权衡，同时也要避免在尖峰时段出现专案中断。

值得注意的是，关税环境对不同产业和地区的影响存在差异，那些已整合国内生产或拥有免税供应链的公司从中受益。这也活性化了关于近岸外包（即将製剂生产能力转移到更靠近主要需求中心的地方）的讨论。总而言之，这些发展凸显了在成本格局重新平衡的环境下，企业需要积极监控贸易政策并采取灵活的商业性应对措施，才能保持竞争力。

进阶細項分析揭示了作物、配方和最终用途管道如何相互交织，从而影响产品策略和商业化。

基于细分市场的洞察揭示了不同的需求驱动因素和营运重点，这些因素会影响产品策略和市场推广方式。按应用场景划分，叶面喷布因其时间灵活且可与生长季内干预措施兼容，可分为出苗后和出苗前两种情况，其中田间决策占据主导地位；而种子处理和土壤施用则在需要有针对性的残留控製或幼苗保护时发挥着特殊作用。这些细微差别会影响配方选择、施药设备规格以及面向咨询管道的讯息。

基于作物的细分研究表明，玉米、大豆和小麦等作物因其生长週期、杂草频谱和抗性特征而呈现出不同的应用模式。玉米防治方案通常着重于速效除草剂或生长季内滚动施用除草剂，将草铵膦与其他除草剂结合使用，以应对多种杂草；而大豆防治方案则可能优先考虑收穫前或抽穗后针对性地进行除草剂耐受性状的干预。小麦则需要关注抽穗前残效控制和选择性混配，以确保生长季初期获得潜在产量。

製剂的选择——干粉剂、液体剂或水分散颗粒剂——反映了操作便利性、溶解性、应用稳定性以及与农机设备的兼容性之间的权衡。干粉剂可以减轻运输重量和风险，液体剂易于混合且吸收迅速，而水分散颗粒剂则可实现精确计量，并在某些情况下提高储存稳定性。最终用途细分为商业农业、工业和住宅用途，进一步影响了产品特性和法规要求。商业农业追求规模化和成本效益，工业应用需要独特的标籤检视和安全控制，而住宅应用则强调低剂量、易于使用的剂型。

这些细分层级相互交织，共同界定了顾客价值提案、分销策略和研发重点。了解施用方式、作物类型、配方选择和最终用途环境之间的相互作用，对于设计既能满足田间实际需求又能符合监管和通路限制的产品和商业性策略至关重要。

对美洲、欧洲、中东和非洲以及亚太地区的需求驱动因素、法规环境和供应链结构进行跨区域分析

美洲、欧洲、中东和非洲以及亚太地区的区域驱动因素正在以截然不同的方式塑造需求模式、法规环境和供应链结构。在美洲，多样化的种植系统和大规模商业性农业催生了对操作灵活性更高的除草剂的强劲需求，而一些地区仍然受到鼓励使用成熟化学物质并严格管理的法律规范的约束。南北贸易流动和物流基础设施也会影响配方创新产品到达种植者手中的速度，进而影响活性成分的筹资策略。

欧洲、中东和非洲的监管审查力度很大，而且往往因地区而异。有些市场会进行严格的环境评估，而有些市场则优先考虑基本农业投入品的供应。这种不均衡的监管环境迫使企业寻求有针对性的註册和特定地区的安全资料包，从而凸显了证明其符合区域永续性预期的重要性。在这些地区，市场进入往往取决于一份完善的资料包和一套经证实有效的管理方案。

在亚太地区，集约化种植系统和快速接受新技术的种植者群体，既需要高效的解决方案，也需要针对当地实际情况量身定制的配方。区域製造地和附近的原料供应商具有成本优势，但监管差异和复杂的进口制度需要谨慎对待。在任何地区，本地分销网络、推广服务和通路合作伙伴都会对产品的普及率产生显着影响，因此，制定在地化的商业化策略对于成功至关重要。

竞争格局分析表明，配方能力、监管灵活性、生产规模和分销能力是核心差异化因素。

草铵膦价值链中的竞争力量取决于製剂能力、监管能力、生产规模和分销网络。拥有强大研发能力和一体化生产能力的公司往往能够维持价格弹性，并能快速应对规格变更或突如其来的需求高峰。相反，依赖契约製造或供应链分散的公司更容易受到投入成本波动和贸易政策变化的影响，这些因素会挤压利润空间并延迟产品上市。

该领域的策略倡议包括：优化产品组合，专注于高性能配方；有针对性地收购配方技术和区域註册资讯；以及共同开发契约加速市场准入并分担监管风险。对应用技术和监管专案的投入也是主要企业脱颖而出的关键因素。强大的分销能力仍然是一项重要的竞争优势，而将农艺咨询服务与售后服务支援共用的网路已被证明在推动商业种植者采用相关产品方面尤为有效。

此外，投资于数位农艺和决策支援工具的公司，透过将产品推荐整合到更广泛的作物管理平台中，正在建立更牢固的客户关係。将产品性能与可验证的环境和职业安全实践相结合的公司，能够满足监管机构和买方主导的永续性要求，从而保障市场进入和高端市场定位。

为製造商、经销商和顾问提供切实可行的建议，以增强配方适应性、监管应对力、供应链灵活性和整合商业策略。

产业领导者可以采取一系列切实可行的措施来保护利润率、加速推广应用并降低草铵膦市场的监管和供应链风险。优先考虑製剂多样化，以满足不同的应用领域和使用者偏好，投资开发符合当地设施标准和储存规范的液体、干粉和颗粒剂型。同时，扩大管理和田间试验项目，以证明其在各种农业操作条件下的功效，并支持重点地区的註册申请。

透过对关键投入品的多个供应商进行资格认证、协商灵活的采购协议以及考虑区域混合和联合包装，增强供应链韧性，从而减轻关税的影响。利用预测性采购和库存管理，平衡高峰期缺货的营运风险和成本。尽可能加快审批流程，并透过积极投资安全和环境资料集、参与产业工作小组以影响政策时间表以及与监管机构保持透明沟通，加强与监管机构的互动。

最后，我们正透过与数位化农艺供应商合作、提供决策支援工具以及建立综合杂草管理咨询管道，将我们的产品融入更广泛的作物管理解决方案中。这种整合式方法提高了产品的相关性，减少了对单一技术解决方案的依赖，并促进了长期管理，同时使我们的销售团队能够阐明引人注目的价值提案，从而证明其高端定位的合理性。

一种透明的、多方法的研究途径，结合了初步的监管访谈和供应链分析、同行检验和有据可查的假设。

本执行摘要的研究基础结合了来自行业相关人员的初步研究、严谨的二次检验以及反覆的专家评审，以确保提供平衡且切实可行的见解。主要研究内容包括对农艺师、配方研发人员、供应链经理和监管专家的结构化访谈，从而获得对田间优先事项和商业性限制因素的第一手观察。此外，还对分销网络进行了调查，以了解不同终端用户管道和种植系统中产品的推广应用驱动因素。

二手研究查阅了监管文件、专家农艺研究、配方专利和贸易政策出版物，并将其与一手研究联繫起来，以识别跨区域模式。透过供应链映射，追踪关键物质的流动，识别前驱供应中的浓度风险，并评估关税方案的潜在影响。所有数据均与多个资讯来源进行交叉核对，并由专家小组审核。

为了提高研究的可重复性和透明度，我们详细记录了市场区隔、地理分析和影响分析方法，以及决策规则、纳入标准和假设。我们进行了敏感度分析，以了解监管时间表、关税水平和杂草抗药性流行程度的变化如何影响战略重点，从而为相关人员提供了一个框架，以便他们根据自身的风险接受度和运营限制调整我们的建议。

策略结论强调了製剂创新、监管参与和供应链灵活性对于确保草铵膦长期市场地位的重要性。

总而言之，草铵膦仍然是现代杂草管理的重要工具，但其未来发展轨迹将取决于相关人员如何应对监管压力、供应链变化以及不断变化的种植者期望。投资配方创新、加强监管体係以及提高供应链灵活性以抵御关税引起的成本波动是关键挑战。那些积极主动地将产品开发与当地农艺需求和监管实际情况相结合的公司，将更有利于进入市场并保持商业性竞争力。

未来前景将有利于那些能够将卓越技术、灵活营运和清晰的客户价值沟通相结合的公司。透过将草铵膦产品整合到更广泛的作物管理解决方案中，并展现可衡量的安全性和环境绩效，即使在复杂的市场环境中，这些公司也能保护净利率并抓住成长机会。最终，策略重点、基于证据的监管沟通以及严谨的执行力将决定哪些公司能够成功地将当前的挑战转化为长期优势。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在抗Glyphosate杂草管理专案中，越来越多地采用草铵膦类除草剂混合物
  • 北美和欧盟农业市场对草铵膦使用的监管核准和限制
  • 开发高浓度配方，以提高疗效并减少用量。
  • 透过将草铵膦与精密农业技术结合，实现有针对性的杂草控制
  • 专利到期对草铵膦定价和非专利除草剂生产商准入的影响
  • 新兴国家对草铵膦的需求不断增长，这主要得益于永续农业倡议的推动。
  • 供应链挑战和活性成分采购影响草铵膦的供应和成本趋势。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8.草铵膦市场应用

  • 叶面喷布
    • 出苗后
    • 出苗前
  • 种子处理
  • 土壤

9. 按作物分類的草铵膦市场

  • 玉米
  • 大豆
  • 小麦

第十章 按剂型分類的草铵膦市场

  • 干粉状可流动
  • 液体
  • 水分散性颗粒

11.草铵膦市场（依最终用途）

  • 商业农业
  • 工业的
  • 住宅

第十二章 各地区草铵膦市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章：按群体分類的草铵膦市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国草铵膦市场概况

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • BASF SE
    • Bayer AG
    • UPL Limited
    • ADAMA Ltd
    • Nufarm Limited
    • Sipcam Oxon SpA
    • Sumitomo Chemical Co., Ltd
    • Zhejiang Xinan Chemical Industrial Group Co., Ltd
    • Gowan Company LLC
    • Qingdao Seawin Biotech Group
Product Code: MRR-C002B1C994EB

The Glufosinate Market is projected to grow by USD 4.29 billion at a CAGR of 10.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.97 billion
Estimated Year [2025] USD 2.17 billion
Forecast Year [2032] USD 4.29 billion
CAGR (%) 10.20%

Comprehensive introduction to the evolving glufosinate landscape outlining agronomic roles regulatory pressures supply chain dynamics and commercial relevance

Glufosinate occupies a distinct position within modern agronomy, serving as a non-glyphosate option in integrated weed control programs and as a complement to resistance management strategies. Its herbicidal mode of action, regulatory profile, and formulation flexibility have maintained relevance across diverse cropping systems, while shifting regulatory scrutiny and evolving grower preferences continually reshape how the product is deployed. Over recent seasons, stakeholders have balanced efficacy against environmental and regulatory considerations, prompting innovation in formulation, application timing, and stewardship practices.

Beyond agronomic performance, the product's commercial lifecycle is influenced by upstream raw material sourcing, formulant availability, and downstream regulatory approvals. As growers seek resilient weed control programs, demand patterns reflect both compliance drivers and practical field performance, with particular emphasis on crops where weed pressure and resistance risks are high. Consequently, manufacturers, formulators, and distributors are placing greater emphasis on integrated approaches that couple chemical tools with cultural and mechanical measures.

Looking ahead, the introduction outlines the cross-cutting forces shaping decisions across product development, market access, and on-farm adoption. By framing the landscape through regulatory dynamics, operational constraints, and end-user expectations, this section sets the context for deeper analysis of segmentation, regional dynamics, and strategic responses necessary for stakeholders to remain competitive and compliant.

Transformative regulatory agronomic technological and commercial forces reshaping glufosinate strategy innovation and supply chain positioning

The glufosinate landscape is undergoing transformative shifts driven by regulatory recalibration, resistance management needs, and a rising emphasis on sustainability. Stricter environmental and toxicological review processes across multiple jurisdictions have forced firms to reassess registration strategies and invest in enhanced safety and stewardship programs. Simultaneously, the proliferation of herbicide-resistant weed populations has elevated the value proposition of alternative modes of action, making glufosinate a strategic component of rotation programs and integrated weed management protocols.

Technological and commercial shifts are also apparent. Formulation science is advancing to improve rainfastness, crop selectivity, and tank-mix compatibility, thereby expanding operational windows for applicators. Digital agronomy tools are enabling precision application that reduces active ingredient use while maximizing efficacy, and analytics-driven decision support is helping advisors prescribe combinations that delay resistance onset. On the supply side, consolidation among formulators and distributors continues to reshape access and pricing dynamics, with partnerships and contract manufacturing playing an increasingly important role.

Moreover, sustainability commitments from major buyers and retailers are pressuring supply chains to demonstrate lower environmental footprints and robust stewardship. This confluence of regulatory oversight, agronomic necessity, and commercial sustainability requirements is driving portfolio rationalization and innovation, creating both challenges and opportunities for incumbents and new entrants alike.

Assessment of the 2025 tariff-driven supply chain disruptions and commercial cost implications for glufosinate sourcing manufacturing and market access strategies

The imposition of tariffs and trade measures in the United States in 2025 has materially altered cost structures and sourcing decisions for players within the glufosinate value chain. Increased duties on certain precursor chemicals and formulation inputs have elevated landed costs for some import-dependent manufacturers, prompting rapid reassessment of supplier relationships and logistics models. These trade policy shifts have emphasized the importance of supply-chain visibility, multi-sourcing strategies, and localized manufacturing options to preserve margin and maintain supply continuity.

As a consequence, manufacturers and formulators have had to weigh the trade-offs between passing higher costs to downstream customers and absorbing margin compressions. In many cases, commercial teams implemented targeted price adjustments alongside enhanced value messaging to justify changes, while procurement functions accelerated qualification of alternative suppliers from lower-tariff jurisdictions. The tariff environment also strengthened incentives for forward contracting and inventory hedging, with companies balancing working capital impacts against the need to avoid program disruptions during peak application seasons.

Importantly, the tariff landscape created a differential impact across segments and regions, benefiting firms with integrated domestic production or those with secure access to tariff-exempt supply chains. It also stimulated conversations about nearshoring and co-locating formulation capacity closer to key demand centers. Collectively, these developments have underscored the necessity of proactive trade-policy monitoring and agile commercial responses to preserve competitiveness in a recalibrated cost environment.

Nuanced segmentation analysis revealing how application modes crops formulations and end-use channels intersect to shape product strategy and commercialization

Segmentation-driven insights reveal differentiated demand drivers and operational priorities that influence product strategy and go-to-market approaches. When examined by application, foliar use-divided into post-emergence and pre-emergence scenarios-dominates field-level decision-making due to flexibility in timing and compatibility with in-season interventions, while seed treatment and soil applications serve niche roles where targeted residual control or seedling protection is required. These subtleties impact formulation choices, application equipment specifications, and stewardship messaging for advisory channels.

Crop-based segmentation shows that crops such as corn, soybean, and wheat present distinct use-case patterns rooted in cropping cycles, weed spectra, and tolerance profiles. Corn programs frequently emphasize knockdown and in-season rolling programs that integrate glufosinate with other herbicides to manage diverse weed mixes, whereas soybean programs may prioritize pre-harvest or targeted post-emergence interventions that align with herbicide-tolerance traits. Wheat systems often require attention to pre-emergence residual control and selective tank mixes to protect yield potential during early growth stages.

Formulation preferences-spanning dry flowable, liquid, and water dispersible granules-reflect trade-offs between handling convenience, solubility, spray stability, and on-farm equipment compatibility. Dry flowables can reduce shipping weight and risk, liquids offer ease of mixing and rapid uptake, and water dispersible granules provide precise dosing and improved storage stability for certain channels. End-use segmentation into commercial agriculture, industrial, and residential applications further modulates product characteristics and regulatory demands, with commercial agriculture driving scale and cost-efficiency, industrial uses requiring tailored labeling and safety controls, and residential applications focusing on low-dose, user-friendly formats.

Together, these segmentation layers intersect to define customer value propositions, distribution strategies, and R&D priorities. Understanding how application mode, crop type, formulation choice, and end-use context interact is essential for designing products and commercial approaches that meet field-level expectations while satisfying regulatory and channel constraints.

Cross-regional analysis of demand drivers regulatory environments and supply chain structures across the Americas Europe Middle East & Africa and Asia-Pacific

Regional dynamics shape demand patterns, regulatory exposure, and supply chain architectures in materially different ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, diverse cropping systems and large-scale commercial agriculture create robust demand for operationally flexible herbicides, while regulatory frameworks in some jurisdictions remain conducive to the use of established chemistries under strict stewardship. North-South trade flows and logistical infrastructure also determine how quickly formulation innovations reach growers and influence procurement strategies for active ingredients.

Within Europe, Middle East & Africa, regulatory scrutiny is often intense and variable by sub-region, with some markets enforcing stringent environmental assessments and others prioritizing access for essential agricultural inputs. This uneven regulatory landscape compels firms to pursue targeted registrations and localized safety data packages, and it elevates the importance of demonstrating compliance with regional sustainability expectations. Market access in these geographies frequently hinges on robust data packages and demonstrated stewardship programs.

In the Asia-Pacific region, high-intensity cropping systems and fast-adopting grower communities create demand for both high-efficacy solutions and specialized formulations that accommodate local practices. Regional manufacturing hubs and proximate raw material suppliers can offer cost advantages, but regulatory variability and complex import regimes require careful navigation. Across all regions, local distribution networks, extension services, and channel partners significantly influence adoption velocity, making regionally tailored commercialization strategies essential for success.

Competitive landscape analysis emphasizing formulation capability regulatory agility manufacturing scale and distribution strength as core differentiators

Competitive dynamics in the glufosinate value chain are shaped by capabilities in formulation, regulatory affairs, production scale, and channel reach. Firms that combine robust R&D with integrated manufacturing capacity tend to retain pricing flexibility and can respond more rapidly to specification changes or sudden demand spikes. Conversely, companies that rely on contract manufacturing or fragmented supply chains are more exposed to input cost volatility and trade-policy shifts, which can compress margins or delay product launches.

Strategic behaviors observed in the sector include portfolio rationalization to focus on high-performing formulations, targeted acquisitions to acquire formulation technology or regional registrations, and co-development agreements that accelerate market entry while sharing regulatory risk. Investment in application technology and stewardship programs also differentiates leading companies, as buyers increasingly demand verifiable safety and efficacy data. Distribution strength remains a critical competitive advantage, with networks that combine agronomic advisory services and after-sales support proving particularly effective at driving adoption among commercial growers.

Additionally, companies investing in digital agronomy and decision-support tools are creating stickier customer relationships by embedding product recommendations within broader crop management platforms. Those that couple product performance with demonstrable environmental and occupational safety measures are better positioned to meet the convergence of regulatory and buyer-driven sustainability requirements, thereby protecting market access and premium positioning.

Actionable recommendations for manufacturers distributors and advisors to enhance formulation resilience regulatory readiness supply-chain agility and integrated commercial strategies

Industry leaders can adopt a series of practical measures to protect margins, accelerate adoption, and reduce regulatory and supply-chain risk in the glufosinate market. Prioritize formulation diversification to address varied application windows and handler preferences, investing in liquid, dry flowable, and granule formats that align with local equipment norms and storage realities. At the same time, expand stewardship and field-trial programs that document efficacy under diverse agronomic conditions and support registration dossiers across priority jurisdictions.

Strengthen supply-chain resilience by qualifying multiple suppliers for critical inputs, negotiating flexible sourcing agreements, and considering localized blending or co-packing to mitigate tariff exposure. Use predictive procurement and inventory management to balance cost against the operational risk of stockouts during peak seasons. Enhance regulatory engagement by proactively investing in safety and environmental datasets, participating in industry working groups to influence policy timelines, and maintaining transparent communication with regulators to expedite approvals when possible.

Finally, embed product offerings within broader crop management solutions by partnering with digital agronomy providers, offering decision-support tools, and training advisory channels on integrated weed management. These integrated approaches increase product relevance, reduce reliance on single-technology solutions, and enable commercial teams to articulate a compelling value proposition that justifies premium positioning while promoting long-term stewardship.

Transparent multi-method research approach integrating primary interviews regulatory and supply-chain analysis with expert validation and documented assumptions

The research underpinning this executive summary combined primary engagement with industry stakeholders, rigorous secondary-source validation, and iterative expert review to ensure balanced and actionable findings. Primary inputs included structured interviews with agronomists, formulators, supply-chain managers, and regulatory specialists, enabling direct observation of field-level priorities and commercial constraints. These interviews were complemented by targeted surveys of distribution networks to capture adoption drivers across different end-use channels and cropping systems.

Secondary research encompassed regulatory filings, peer-reviewed agronomic studies, formulation patents, and trade policy publications to contextualize primary observations and identify cross-jurisdictional patterns. Supply-chain mapping exercises traced key material flows, identified concentration risks in precursor supply, and evaluated potential impacts from tariff scenarios. All data points were cross-checked against multiple sources and reviewed by an expert panel to reconcile divergent perspectives and ensure analytic rigor.

To enhance reproducibility and transparency, methodologies for segmentation, regional analysis, and impact assessment were documented with decision rules, inclusion criteria, and assumptions. Sensitivity analyses were performed to understand how variations in regulatory timelines, tariff levels, and weed-resistance prevalence could influence strategic priorities, thereby providing stakeholders with a framework to adapt recommendations to their specific risk tolerance and operational constraints.

Strategic conclusion emphasizing the importance of formulation innovation regulatory engagement and supply-chain agility to secure long-term glufosinate relevance

In conclusion, glufosinate remains an important tool within modern weed management arsenals, but its future trajectory is contingent on how well stakeholders navigate regulatory pressures, supply-chain shifts, and evolving grower expectations. Key imperatives include investing in formulation innovation, strengthening stewardship frameworks, and enhancing supply-chain flexibility to withstand tariff-driven cost volatility. Firms that proactively align product development with region-specific agronomic needs and regulatory realities will be better positioned to sustain market access and commercial relevance.

The road ahead favors those who can couple technical excellence with operational agility and clear value communication to customers. By integrating glufosinate offerings into broader crop management solutions and by demonstrating measurable safety and environmental performance, companies can preserve margins and unlock growth opportunities even as the market environment becomes more complex. Ultimately, strategic focus, evidence-based regulatory engagement, and disciplined execution will determine which organizations successfully convert current challenges into long-term advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of glufosinate-based herbicide mixtures in glyphosate resistant weed management programs
  • 5.2. Regulatory approvals and restrictions for glufosinate use across North American and EU agricultural markets
  • 5.3. Development of high-concentration glufosinate formulations to improve efficacy and reduce application rates
  • 5.4. Integration of glufosinate with precision agriculture technologies for targeted weed control
  • 5.5. Impact of patent expirations on glufosinate pricing and entry of generic herbicide manufacturers
  • 5.6. Expansion of glufosinate demand in emerging economies driven by sustainable agriculture initiatives
  • 5.7. Supply chain challenges and active ingredient sourcing affecting glufosinate availability and cost dynamics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glufosinate Market, by Application

  • 8.1. Foliar
    • 8.1.1. Post Emergence
    • 8.1.2. Pre Emergence
  • 8.2. Seed Treatment
  • 8.3. Soil

9. Glufosinate Market, by Crop

  • 9.1. Corn
  • 9.2. Soybean
  • 9.3. Wheat

10. Glufosinate Market, by Formulation

  • 10.1. Dry Flowable
  • 10.2. Liquid
  • 10.3. Water Dispersible Granules

11. Glufosinate Market, by End Use

  • 11.1. Commercial Agriculture
  • 11.2. Industrial
  • 11.3. Residential

12. Glufosinate Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glufosinate Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glufosinate Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BASF SE
    • 15.3.2. Bayer AG
    • 15.3.3. UPL Limited
    • 15.3.4. ADAMA Ltd
    • 15.3.5. Nufarm Limited
    • 15.3.6. Sipcam Oxon S.p.A
    • 15.3.7. Sumitomo Chemical Co., Ltd
    • 15.3.8. Zhejiang Xinan Chemical Industrial Group Co., Ltd
    • 15.3.9. Gowan Company LLC
    • 15.3.10. Qingdao Seawin Biotech Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GLUFOSINATE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GLUFOSINATE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GLUFOSINATE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GLUFOSINATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GLUFOSINATE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS GLUFOSINATE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS GLUFOSINATE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 166. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 173. AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 178. AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. ASEAN GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. ASEAN GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. ASEAN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. ASEAN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. ASEAN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 204. ASEAN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 211. GCC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GCC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GCC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. GCC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. GCC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 216. GCC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 217. GCC GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 218. GCC GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 219. GCC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 220. GCC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 221. GCC GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 222. GCC GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 235. BRICS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. BRICS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. BRICS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. BRICS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. BRICS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 240. BRICS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 247. G7 GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. G7 GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. G7 GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. G7 GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. G7 GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 252. G7 GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 253. G7 GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 254. G7 GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 255. G7 GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 256. G7 GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 257. G7 GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 258. G7 GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 259. NATO GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. NATO GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. NATO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. NATO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. NATO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 264. NATO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 265. NATO GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 266. NATO GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 267. NATO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 268. NATO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 269. NATO GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 270. NATO GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED STATES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED STATES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED STATES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED STATES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED STATES GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED STATES GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 283. CANADA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. CANADA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. CANADA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 286. CANADA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 287. CANADA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 288. CANADA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 293. MEXICO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. MEXICO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 297. MEXICO GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 298. MEXICO GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 301. MEXICO GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 303. BRAZIL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRAZIL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRAZIL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 306. BRAZIL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 307. BRAZIL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 308. BRAZIL GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 309. BRAZIL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 310. BRAZIL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 311. BRAZIL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 312. BRAZIL GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 323. GERMANY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. GERMANY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. GERMANY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 326. GERMANY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 327. GERMANY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 328. GERMANY GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 329. GERMANY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 330. GERMANY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 331. GERMANY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 332. GERMANY GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 333. FRANCE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. FRANCE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. FRANCE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 336. FRANCE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 337. FRANCE GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 338. FRANCE GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 339. FRANCE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 340. FRANCE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 341. FRANCE GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 342. FRANCE GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 343. RUSSIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 344. RUSSIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 345. RUSSIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 346. RUSSIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 347. RUSSIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 348. RUSSIA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 349. RUSSIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 350. RUSSIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 351. RUSSIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 352. RUSSIA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 353. ITALY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 354. ITALY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 355. ITALY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 356. ITALY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 357. ITALY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 358. ITALY GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 359. ITALY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 360. ITALY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 361. ITALY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 362. ITALY GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 363. SPAIN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 364. SPAIN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 365. SPAIN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 366. SPAIN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 367. SPAIN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 368. SPAIN GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 369. SPAIN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 370. SPAIN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 371. SPAIN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 372. SPAIN GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 373. CHINA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 374. CHINA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 375. CHINA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 376. CHINA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 377. CHINA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 378. CHINA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 379. CHINA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 380. CHINA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 381. CHINA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 382. CHINA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 383. INDIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 384. INDIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 385. INDIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 386. INDIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 387. INDIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 388. INDIA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 389. INDIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 390. INDIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2